Joel Hoffman is a member of Sutherland’s Litigation Practice Group, representing manufacturers and their trade associations in the industries regulated by the U.S. Food and Drug Administration. He leads the firm’s FDA practice.

Joel’s clients have included national organizations in the medical and pharmaceutical professions, on both FDA and health policy/antitrust matters. He is experienced in providing a wide range of legal services, including preventive counseling and business planning advice, representation in formal and informal matters at the FDA and the Drug Enforcement Administration, litigation against the government or competitors in both trial and appellate courts—including the U.S. Supreme Court, drafting proposed regulatory legislation, and representing his clients’ interests at all stages of the legislative process.

Joel began his legal career at the U.S. Department of Justice, handling administrative law and antitrust cases. He frequently speaks at seminars and conferences sponsored by the American Bar Association and by the Food and Drug Law Institute (FDLI). Joel has written numerous articles in the Food and Drug Law Journal (FDLI), The Business Lawyer (ABA Section of Business Law) and The Administrative Law Review (ABA Section of Administrative Law and Regulatory Practice).